Genesis 2010, Westminster, Thursday 9 December is on track to attract a larger than ever attendance to debate new medicines and healthcare products research. More
Two probiotic strains “GM-080” and “GMNL-33,” developed and marketed by GenMont Biotech Inc., (TWOTC: 3164) have been approved by regulatory agencies in China, and can now be used as additive ingredients to food products in that market. More
Cambridge, 4 November 2010 - One Nucleus, the not-for-profit membership company for international life science and healthcare companies, is to launch a series of high level conferences focused on specific technology areas, replacing its annual BioPartneri More
Sinclair Pharma plc announces today that John O. Butler Mexico, part of the international Sunstar Group, has signed a marketing and distribution agreement for Mexico for all three Aloclair® products, Sinclair's treatments for mouth ulcers. More
Zambon Group S.p.A. and Access Pharmaceuticals Inc. have announced the signing Licensing Agreement granting Zambon Group the marketing rights for amlexanox for the treatment of canker sores. More
Sinclair Pharma plc, the specialty pharmaceutical ompany, announces that it has licensed the exclusive US rights of one of its key products, Decapinol® Rinse, to OraPharma, Inc., a subsidiary of Johnson & Johnson More
Displaying 1..10 of 50 -
per page
Next page
Order by